Using imaging biomarkers of hypoxia to improve diagnostic and prognostics in GBM management.
This study is designed to evaluate the role of Oxygen Enhanced (OE) Magnetic resonance imaging (MRI) and Blood Oxygenation Level Dependent (BOLD) MRI in detecting regions of hypoxic tumour and to evaluate their use as imaging methods to selectively deliver targeted radiotherapy to regions of aggressive disease.
Trial information page: https://clinicaltrials.gov/study/NCT05500612
Trial protocol paper: https://pubmed.ncbi.nlm.nih.gov/38192626/